Humana limits Spinraza coverage

In a coverage policy note, Humana Inc. (NYSE:HUM) said it considers Spinraza nusinersen from Biogen Inc. (NASDAQ:BIIB) to be “medically necessary”

Read the full 210 word article

User Sign In